Nordic Bioscience: NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen

(marketscreener.com) BELTSVILLE, Md., Sept. 07, 2023 -- NextCure, Inc. , a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the publication of a review article in the online journal Frontiers in Immunology, highlighting the...https://www.marketscreener.com/quote/stock/NEXTCURE-INC-57878446/news/NextCure-and-Nordic-Bioscience-Publish-Review-Article-on-the-Regulation-of-Tumor-Immunity-by-Tumor-C-44797442/?utm_medium=RSS&utm_content=20230907